AVA-TRAP

Welcome to the Brand page for “AVA-TRAP”, which is offered here for Pharmaceutical preparations and components thereof for treatment of infectious disease, qty-code designed cytokine and chemokine receptor protein variants with antibody-like properties used to trap cytokines, chemokines and inflammatory mediators released by immune effector cells during pathophysiological conditions, including but not limited to cytokine release syndrome associated with car-t therapy, coronavirus-induced lung damage, and other such similar pathophysiological conditions;.

Its status is currently believed to be active. Its class is unavailable. “AVA-TRAP” is believed to be currently owned by “Avalon Globocare Corp.”